Phosphate nephropathy

Revision as of 15:17, 27 September 2012 by Esther Lee (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Phosphate nephropathy Microchapters

Home

Patient Information

Overview

Pathophysiology

Causes

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Biopsy

X Ray

Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Phosphate nephropathy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Phosphate nephropathy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Phosphate nephropathy

CDC on Phosphate nephropathy

Phosphate nephropathy in the news

Blogs on Phosphate nephropathy

Directions to Hospitals Treating Phosphate nephropathy

Risk calculators and risk factors for Phosphate nephropathy

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Pathophysiology

Causes

Differentiating Phosphate nephropathy from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria | History and Symptoms | Physical Examination | Laboratory Findings | Phosphate nephropathy biopsyBiopsy]] | X ray | Ultrasound | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1


Phosphate nephropathy consists of damage to the kidneys caused by the formation of phosphate crystals within the renal tubules, damaging the nephron, and can cause acute renal insufficiency or acute renal failure.

It frequently occurs following the ingestion of oral sodium phosphate solution (Visicol) for bowel cleansing prior to a colonoscopy. The risk of this complication is increased with age, underhydration, or in the presence of hypertension or if the patient is taking an ACE inhibitor or angiotensin receptor blocker. Other agents used for bowel preparation (e.g. magnesium citrate or PEG-3350 & electrolyte-based purgatives such as Colyte or Golytely) do not carry this risk.

When a kidney damaged by phosphate nephropathy is biopsied, the pathological findings are typical of nephrocalcinosis: diffuse tubular injury with calcium phosphate crystal deposition.

Template:WH Template:WS